Finding 582942 (2022-003)

Material Weakness Repeat Finding
Requirement
ABCIL
Questioned Costs
-
Year
2022
Accepted
2023-12-26
Audit: 8469
Organization: Palo Alto County Hospital (IA)

AI Summary

  • Core Issue: The Health System lacks formal controls and procedures for compliance with federal awards, increasing the risk of improper fund use.
  • Impacted Requirements: Failure to meet 2 CFR 200.303(a) regarding effective internal controls over federal awards.
  • Recommended Follow-Up: Implement formal review processes for fund usage and reporting, ensuring segregation of duties and retaining documentation of approvals.

Finding Text

Federal agency: U.S. Department of Health and Human Services Federal program title: Rural Communities Opioid Response Program – Medication Assisted Treatment (MAT) Expansion and COVID-19 Rural Health Clinic Vaccine Confidence Assistance Listing Number: 93.912 Award Period: September 1, 2019 through August 31, 2022 Type of Finding: • Material Weakness in Internal Control over Compliance Criteria or specific requirement: 2 CFR 200.303(a) states that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and conditions of the federal award. The Health System did not have documented formal controls and procedures over compliance with federal awards. Condition: The Health System did not have documented formal review processes over the use of the federal awards or required reporting for the federal awards. Eligible uses of federal awards were tracked in detail, and required reporting under the federal award was completed, but there was not a formal review or approval process in place. Questioned costs: None Context: The Health System maintained detailed records of eligible uses of federal funds for tracking and required reporting purposes. The Health System's CFO maintained this schedule as eligible uses of funds were identified throughout the organization, reviewed activity, and reconciled the schedule to the general ledger. There was not, however, documentation of a formal review or approval, outside of the schedule being maintained and reconciled. Similarly, the Health System CFO completed the required reporting under the federal award based on the schedule discussed above and other supporting documentation, but there was no formal review or approval process for that report. The Health System does have in place review processes and controls over all expenditures (AP, Payroll), they are just not designed specifically to consider compliance with federal programs. Cause: The Health System has not previously received federal awards in an amount sufficient to require an audit under Uniform Guidance. Therefore more formal controls and procedures around the use of federal awards had not been in place. Effect: Without formal control and review processes in place over use of federal funds or required reporting under those awards, there is a greater risk of improper use of funds or misstatement in required reporting. Repeat finding: Yes – 2021-003 Recommendation: We recommend that management implement more formal control process surrounding the use of federal awards where there is segregation between individuals identifying or proposing expenditures/uses of funds and an individual reviewing and approving that expenditure/use. We also recommend for any formal reporting required under federal awards that there be a formal review process where an individual is reviewing and approving the report who did not prepare the report. Documentation of review and approval should be retained in both cases. Views of responsible officials: There is no disagreement with the audit finding.

Categories

Material Weakness Reporting Internal Control / Segregation of Duties

Other Findings in this Audit

  • 6497 2022-003
    Material Weakness Repeat
  • 6498 2022-004
    Significant Deficiency
  • 6499 2022-005
    Significant Deficiency
  • 6500 2022-003
    Material Weakness Repeat
  • 6501 2022-004
    Significant Deficiency
  • 6502 2022-005
    Significant Deficiency
  • 582939 2022-003
    Material Weakness Repeat
  • 582940 2022-004
    Significant Deficiency
  • 582941 2022-005
    Significant Deficiency
  • 582943 2022-004
    Significant Deficiency
  • 582944 2022-005
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.697 Covid-19 Testing for Rural Health Clinics $271,754
93.498 Provider Relief Fund $175,333
93.301 Small Rural Hospital Improvement Grant Program $94,306
21.019 Coronavirus Relief Fund $68,358
93.912 Rural Health Care Services Outreach, Rural Health Network Development and Small Health Care Provider Quality Improvement $65,347
93.889 National Bioterrorism Hospital Preparedness Program $6,232